Jump to content

Stemcell Technologies

From Wikipedia, the free encyclopedia
(Redirected from STEMCELL Technologies)
STEMCELL Technologies
Company typePrivate
IndustryBiotechnology
Founded1993; 31 years ago (1993)
FounderAllen Eaves
Headquarters,
Key people
Allen Eaves, Chairman & CEO
Number of employees
> 2000
Websitestemcell.com

StemCell Technologies Canada Inc. (formerly known as StemCell Technologies Inc.) is a Canadian biotechnology company that develops and manufactures cell culture media and cell separation technologies for use in stem cell, immunology, and cancer research.[1][2]

The company has offices in the United States, Europe, Asia, and Australia with the headquarter being in Vancouver, British Columbia, Canada.[1][3] Allen Eaves, the founder, currently serves as the President and CEO.

History

[edit]

Allen Eaves, a hematologist and cancer researcher, co-founded the Terry Fox Laboratory (TFL) in Vancouver with his wife, hematologist and cancer researcher Connie Eaves, in 1981. Allen Eaves’ research group at the TFL made their own standardized cell culture medium for growing hematopoietic stem cells in the lab. To help fund his blood cancer research program at the TFL, Eaves started selling this medium—named MethoCult—to other research groups around the world. Eaves purchased the business from TFL and launched Stemcell Technologies Inc. in 1993.[4]

In 2018, Stemcell received a $45 million grant from the Canadian and British Columbian governments toward building an advanced biologicals manufacturing facility in Burnaby, British Columbia.[5][6][7]

In 2021, Stemcell launched "The Immunology Podcast" about current scientific advances in the field of immunology with interviews of immunologists.[8]

References

[edit]
  1. ^ a b "Spotlight: STEMCELL Technologies". CME. Retrieved 1 March 2022.
  2. ^ "Improving the efficiency and accuracy of cell research". nrc.canada.ca. 10 December 2021. Retrieved 1 March 2022.
  3. ^ "B.C.'s 'world-class' biotech sector plays key role in developing COVID-19 treatments and vaccines". Vancouver Sun. Retrieved 1 March 2022.
  4. ^ "Meet Allen Eaves: Academic Biologist turned CEO | Eurostemcell". www.eurostemcell.org. Retrieved 1 March 2022.
  5. ^ "Federal and provincial governments support creation of biotech manufacturing facility in the Lower Mainland". www.canada.ca. 25 April 2018. Retrieved 1 March 2022.
  6. ^ "Hundreds of new jobs expected as B.C. biotech firm plans new facility". cbc.ca. Retrieved 2 March 2022.
  7. ^ "Burnaby tech company gets $45 million". Burnaby Now. Retrieved 2 March 2022.
  8. ^ "Our Story". The Immunology Podcast. Retrieved 2024-01-18.


[edit]